THERAPEUTIC AGENT FOR INFLAMMATORY DISEASE

摘要

The present invention relates to a therapeutic agent for histone-induced inflammation, said therapeutic agent comprising a monoclonal antibody, or an antigen-binding fragment thereof, which can bind to a peptide comprising an amino acid sequence represented by SSVLYGGPPSAA (SEQ ID NO:1) or a conjugate of said peptide with a pharmaceutically acceptable carrier.